Efficacy and mechanism-of-action of a novel superagonist interleukin-15: Interleukin-15 receptor αSu/Fc fusion complex in syngeneic murine models of multiple myeloma

导出原文传递

翻译打印收藏纠错

作者： Xu,W. ^[1] ; Jones,M. ^[2] ; Liu,B. ^[3] ; Zhu,X. ; Johnson,C.B. ; Edwards,A.C. ; Kong,L. ; Jeng,E.K. ; Han,K. ; Marcus,W.D. ; Rubinstein,M.P. ; Rhode,P.R. ; Wong,H.C.

作者单位： Altor BioScience Corporation, Miramar, FL, United States ^[1] Medical University of South Carolina, Charleston, SC, United States ^[2] Altor BioScience Corporation, Miramar, FL, United States, Altor BioScience Corporation, 2810 North ^[3]

发布时间 2013-12-19

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Cancer research

2013年73卷10期

3075-3086页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Efficacy and mechanism-of-action of a novel superagonist interleukin-15: Interleukin-15 receptor αSu/Fc fusion complex in syngeneic murine models of multiple myeloma

Cancer research

相似文献

Cancer research

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Efficacy and mechanism-of-action of a novel superagonist interleukin-15: Interleukin-15 receptor αSu/Fc fusion complex in syngeneic murine models of multiple myeloma

Cancer research

相似文献

Cancer research

相关期刊

检索历史清除